GlobeNewswire
-
Transparency Notification from Shareholders
06/01/2026 -
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)
06/01/2026 -
Teclison, Inc. to Participate in ASCO Gastrointestinal Cancers Symposium
06/01/2026 -
PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVID Program
06/01/2026 -
Dewpoint Therapeutics Launches Initiative to Build Viral Condensate Phenomics Atlas for HPV
06/01/2026 -
SoldierStrong Announces Annual SoldierScholar Recipients For 2025
06/01/2026 -
Medtech Incubator Partners with Leap Distributors to Support U.S. Market Expansion Efforts
06/01/2026 -
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
06/01/2026 -
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Olympia Pharmaceuticals Launches Rebranded Website, Ushering in a New Era of Seamless Navigation and Advanced Features
06/01/2026 -
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
06/01/2026 -
Day One Completes Acquisition of Mersana Therapeutics
06/01/2026 -
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
06/01/2026 -
CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk
04/01/2026 -
Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges
03/01/2026 -
Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain
02/01/2026 -
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02/01/2026 -
Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
02/01/2026 -
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02/01/2026
Pages